Free Trial

Aldeyra Therapeutics (ALDX) Insider Trading & Ownership

Aldeyra Therapeutics logo
$4.76 -0.18 (-3.64%)
(As of 11/20/2024 ET)

Aldeyra Therapeutics (NASDAQ:ALDX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.50%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$1.47 M
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$365,194.19
Get ALDX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aldeyra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ALDX Insider Buying and Selling by Quarter

Aldeyra Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/5/2024Perceptive Advisors LlcMajor ShareholderBuy37,712$4.74$178,754.88  
4/3/2024Perceptive Advisors LlcMajor ShareholderBuy309,847$4.09$1,267,274.23  
4/1/2024Perceptive Advisors LlcMajor ShareholderBuy8,374$3.25$27,215.50  
3/11/2024Bruce GreenbergInsiderSell13,201$3.41$45,015.41  
3/11/2024Todd C BradyCEOSell97,914$3.27$320,178.78  
(Data available from 1/1/2013 forward)

ALDX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Aldeyra Therapeutics includes Bruce Greenberg, Martin Joseph Joyce, Nancy Miller-Rich, Perceptive Advisors Llc, and Todd C Brady. Learn more on insiders at ALDX.

8.50% of Aldeyra Therapeutics stock is owned by insiders. Learn more on ALDX's insider holdings.

The following insiders have purchased ALDX shares in the last 24 months: Nancy Miller-Rich ($5,156.17), and Perceptive Advisors Llc ($1,473,244.61).

Insiders have purchased a total of 356,442 ALDX shares in the last 24 months for a total of $1,478,400.78 bought.

The following insiders have sold ALDX shares in the last 24 months: Bruce Greenberg ($45,015.41), Perceptive Advisors Llc ($4,453,308.26), and Todd C Brady ($320,178.78).

Insiders have sold a total of 2,867,614 Aldeyra Therapeutics shares in the last 24 months for a total of $4,818,502.45 sold.

Aldeyra Therapeutics Key Executives

  • Todd C. Brady (Age 48)
    M.D., Ph.D., Chief Executive Officer and Director
  • Joshua Reed (Age 47)
    Chief Financial Officer
  • David McMullin (Age 45)
    Chief Commercial Officer
  • James A. Gow (Age 53)
    M.D., Senior Vice President of Clinical Development
  • Stephen G. Machatha (Age 43)
    Ph.D., Senior Vice President, Technical Operation


This page (NASDAQ:ALDX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners